FRAX597, a PAK1 inhibitor, synergistically reduces pancreatic cancer growth when combined with gemcitabine

Dannel Yeo(The University of Melbourne), Mehrdad Nikfarjam(The University of Melbourne)
BMC Cancer
January 16, 2016
Cited by 53


Related Papers